Benzonatate 87519-0111
Product NDC
87519-0111- Manufacturer
- Anvi Pharmaceuticals Inc
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- May 15, 2026
- Listing Expires
- December 31, 2027
- Application
- ANDA211518
Need to source Benzonatate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Benzonatate | 150 mg/1 |
Drug Class
Non-narcotic Antitussive [EPC]Decreased Tracheobronchial Stretch Receptor Activity [PE]Non-narcotic Antitussive [EPC]
Packaging Options(1)
90 CAPSULE in 1 BOTTLE (87519-111-90)